WSB1 and ovarian carcinoma: In Skov3 ovarian cancer cells, HSYA dose-dependently inhibited proliferation, reduced WD repeat and SOCS box containing 1 (WSB1) gene expression, and enhanced apoptosis, thereby suppressing neuroblastoma and ovarian cancer cell growth (60).